Feb 14 (Reuters) - Nexstim Oyj NXTMH.HE :
* TO LICENSE TECHNOLOGY TO US-BASED MEDICAL TECHNOLOGY
COMPANY
MAGNUS MEDICAL, INC. FOR TREATMENT OF NEUROPSYCHIATRIC DISORDERS
* STRUCTURE OF LICENSE AGREEMENT CONSISTS OF AN UPFRONT
PAYMENT OF
APPROXIMATELY USD 4 MILLION (APPROXIMATELY EUR 3.5 MILLION)
* STRUCTURE OF LICENSE AGREEMENT INCLUDES, BASED ON MAGNUS
MEDICAL'S PROJECTED REVENUE, TECHNOLOGY ROYALTIES OF ABOUT USD
15 MILLION FOR PERIOD OF NOT EXCEEDING 5 YEARS
* MINIMUM ROYALTY PAYMENTS AMOUNT TO ABOUT USD 1.2 MILLION
TO BE
PAID DURING FIRST THREE ROYALTY YEARS
Source text for Eikon: ID:nGNE4zps35
Further company coverage: NXTMH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))